The existence of misdiagnosis does not justify public speculation about what Applegate “really” has. Her medical team has access to evidence the public does not. The honest position is that she says MS has been ruled out and that another explanation has not yet been publicly confirmed.
The Central Vein Sign and Better Imaging
Researchers have been working on tools that can distinguish MS lesions from lesions caused by other conditions. One promising feature is known as the central vein sign.
MS lesions often form around small veins. Specialized MRI techniques can make those veins more visible, allowing clinicians to examine whether lesions have the pattern expected in MS. The sign is not a magical stand-alone answer, but studies suggest it can improve specificity when conventional imaging and clinical evaluation leave uncertainty.
Cedars-Sinai researchers, including neurologist Dr. Marwa Kaisey, have studied the use of the central vein sign in people who had been diagnosed with MS and in people whose diagnosis was later rejected. Kaisey appeared on the second part of Applegate’s podcast discussion to explain why misdiagnosis occurs and why better biomarkers matter.
Reporting about Applegate’s case has connected her reevaluation with newer diagnostic techniques. But the public should be cautious about reconstructing her entire medical file from news summaries. Different reports have emphasized imaging, blood testing, or the broader reassessment. Unless Applegate or her physicians provide a complete clinical account, it is safer to say that updated evaluation led her doctor to conclude the prior diagnosis was incorrect.
The larger point is clear. Diagnostic tools do not remain fixed. A conclusion based on the best available interpretation in 2021 may be revisited when imaging techniques, criteria, specialist knowledge, or the patient’s clinical course provide new evidence.
That is how medicine is supposed to work. Revising a diagnosis is not proof that every earlier clinician acted carelessly. It may reveal an earlier error, but it may also reflect genuine uncertainty and later information. Accountability requires examining the actual process, not assuming either flawless care or obvious malpractice from a headline.
Treatment Given Under the Wrong Diagnosis
Misdiagnosis matters because MS treatments can have meaningful risks. Disease-modifying therapies influence immune activity to reduce relapses or slow disease progression. Depending on the medication, possible burdens can include infections, infusion reactions, monitoring requirements, and other adverse effects.
A person who does not have MS may receive those risks without the intended benefit. Meanwhile, the condition actually causing the symptoms may remain untreated.
Applegate said she had received treatment for years. It is understandable that the public wants to know whether treatment harmed her or whether another approach could have prevented decline. Those questions cannot be answered responsibly from the information available.
It is also important not to tell patients to stop medication because a celebrity was misdiagnosed. A person currently being treated for MS should not treat Applegate’s story as evidence that his or her own diagnosis is wrong. Changes to treatment require individual medical assessment.
The reasonable lesson is narrower: significant chronic diagnoses sometimes merit specialist confirmation, particularly when findings are atypical, treatment is not producing the expected course, or new evidence emerges. A second opinion is not an accusation against the first doctor. It is one tool for managing uncertainty.
Patients also deserve clear conversations about how certain a diagnosis is. “This is definitely MS,” “this is probably MS,” and “we are treating this as MS while we continue to evaluate” are not equivalent statements. Honest communication helps people understand why treatment begins and what evidence might later change the plan.
Why a Diagnosis Becomes Part of Identity
Before chronic illness, identity can feel stable enough to be invisible. A person is a parent, performer, friend, worker, athlete, or traveler. Illness then reorganizes ordinary life. Time becomes divided by appointments. Energy must be budgeted. Devices appear. Other people begin asking questions. The diagnosis becomes a practical explanation for all of it.
For a celebrity, that process happens in public. Applegate’s appearances were discussed through MS. Interviews asked about MS. Her partnership with Sigler was presented through their shared diagnosis. Her humor about mobility and bodily function became part of how audiences understood life with MS.
When the diagnosis was withdrawn, Applegate lost more than a medical label. She lost a map and, temporarily, a recognized membership in a community where she had found understanding.
Her fear that she had let the community down reveals the unequal moral pressure placed on sick public figures. Society asks them to represent millions of patients accurately while they are still trying to survive their own changing condition. They may be praised for raising awareness, then judged when new information complicates the story.
Applegate did what a responsible person should do. She shared the diagnosis she had been given. When that conclusion changed, she shared the change, even though doing so exposed her to confusion and sensational headlines.